Literature DB >> 18648130

Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008.

Muhammad Wasif Saif1.   

Abstract

One of the greatest challenges in the treatment of pancreatic cancer remains its inherent lack of beneficial response to cytotoxic chemotherapy. According to the encyclopedic knowledge on herbal medicine regimen and clinical experience accumulated for centuries, traditional Chinese medicine can provide new avenues for alternative treatments of pancreatic diseases. Chinese herbal extracts have been widely used for the treatment of various cancers, but objective information on their efficacy in pancreatic cancer is lacking. This article provides a summary of herbal medicine, presented at the Annual Meeting of ASCO, 2008. The clinical applications of these active compounds warrant further investigation in randomized, controlled clinical trials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18648130

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  4 in total

Review 1.  Herbals and Plants in the Treatment of Pancreatic Cancer: A Systematic Review of Experimental and Clinical Studies.

Authors:  John K Triantafillidis; Eleni Triantafyllidi; Michail Sideris; Theodoros Pittaras; Apostolos E Papalois
Journal:  Nutrients       Date:  2022-01-30       Impact factor: 5.717

2.  Clinical Efficacy and Safety of Traditional Medicine Preparations Combined With Chemotherapy for Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Authors:  Jiaqi Hu; Juling Jiang; Rui Liu; Mengqi Cheng; Guanghui Zhu; Shulin He; Bolun Shi; Yuwei Zhao; Zhongning He; Huibo Yu; Xing Zhang; Honggang Zheng; Baojin Hua
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

3.  The flavonoid beverage Haelan 951 induces growth arrest and apoptosis in pancreatic carcinoma cell lines in vitro.

Authors:  Juliane Rothe; Michael Wakileh; Katrin Dreißiger; Heike Weber
Journal:  BMC Complement Altern Med       Date:  2015-07-03       Impact factor: 3.659

Review 4.  Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism.

Authors:  Srabani Pal; Ashish Bhattacharjee; Asif Ali; Narayan C Mandal; Subhash C Mandal; Mahadeb Pal
Journal:  J Inflamm (Lond)       Date:  2014-08-09       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.